Pancreatic cancer cells with METTL3 silencing are more susceptible to irradiation, gemcitabine, 5‐FU and L‐OHP, but cell morphology and proliferation are not affected.115. This evidence concerns the gene METTL3 and familial pancreatic carcinoma.